AMRI
Live / Registered — Registered and renewed (as of 31 Jan 2018)
What this means for you
Registered since 25 Dec 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Dec 2017).
Record
- Serial number
- 78928960
- Registration number
- 3360935
- Mark type
- Stylized text
- Filed
- 13 Jul 2006
- Published for opposition
- 27 Feb 2007
- Registered
- 25 Dec 2007
- Next maintenance due
- 25 Dec 2017
- Attorney of record
- Edward T. White
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and chemicals
- Class 042 — Scientific and technological services: Research and development and consultation related thereto in the field of pharmaceuticals and chemicals
Owner
- Albany Molecular Research, Inc., Albany, NY, US
- Albany Molecular Research, Inc., Albany, NY, US
- Albany Molecular Research, Inc., Albany, NY, US
Prosecution history
- 04 Jun 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Jan 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 31 Jan 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 31 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jan 2018 — TEAS SECTION 8 & 9 RECEIVED
- 20 Sept 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 25 Dec 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Jul 2014 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 30 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Dec 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Dec 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 30 Dec 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Dec 2013 — TEAS SECTION 8 & 15 RECEIVED